These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4283643)

  • 1. Determinants of thyroxine-induced cardiac hypertrophy in mice.
    Cohen J; Aroesty JM; Rosenfeld MG
    Circ Res; 1966 Apr; 18(4):388-97. PubMed ID: 4283643
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac protein synthesis and degradation during thyroxine-induced left ventricular hypertrophy.
    Parmacek MS; Magid NM; Lesch M; Decker RS; Samarel AM
    Am J Physiol; 1986 Nov; 251(5 Pt 1):C727-36. PubMed ID: 2946236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of age on thyroxine-induced cardiac hypertrophy in mice.
    Florini JR; Saito Y; Manowitz EJ
    J Gerontol; 1973 Jul; 28(3):293-7. PubMed ID: 4267853
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis.
    Ching GW; Franklyn JA; Stallard TJ; Daykin J; Sheppard MC; Gammage MD
    Heart; 1996 Apr; 75(4):363-8. PubMed ID: 8705762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroxine-induced hypertrophy of the rabbit heart. Effect on regional oxygen extraction, flow, and oxygen consumption.
    Talafih K; Briden KL; Weiss HR
    Circ Res; 1983 Mar; 52(3):272-9. PubMed ID: 6218937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal changes during thyroxine-induced left ventricular hypertrophy in rabbits.
    Parmacek MS; Decker ML; Lesch M; Samarel AM; Decker RS
    Am J Physiol; 1986 Nov; 251(5 Pt 1):C737-47. PubMed ID: 2946237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thyrotoxicosis and recovery on myocardial protein balance.
    Wildenthal K; Sanford CF; Griffin EE; Crie JS
    Adv Myocardiol; 1980; 1():503-7. PubMed ID: 6446743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of reserpine on the heart blood supply].
    Chichkanov GG
    Farmakol Toksikol; 1968; 31(3):269-73. PubMed ID: 5698104
    [No Abstract]   [Full Text] [Related]  

  • 9. Disparate effects of colchicine on thyroxine-induced cardiac hypertrophy and adrenoceptor changes.
    Limas C; Limas CJ
    Circ Res; 1991 Jan; 68(1):309-13. PubMed ID: 1845856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between cGMP and myocardial O2 consumption is altered in T4-induced cardiac hypertrophy.
    Weiss HR; Rodriguez E; Tse J
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H686-91. PubMed ID: 7864195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of findings in hypertrophy of the ventricular myocardium in rats after administration of thyroxine and ligation of the aorta].
    Dudorkinová D; Bouska I; Wachtlová M; Procházka I
    Cesk Patol; 1988 Mar; 24(1):45-52. PubMed ID: 2965997
    [No Abstract]   [Full Text] [Related]  

  • 12. A distinct AMP-activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by L-thyroxine and angiotensin II.
    Jiang SY; Xu M; Ma XW; Xiao H; Zhang YY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):919-25. PubMed ID: 20497424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium.
    Katz E; Zhang Q; Weiss HR; Scholz PM
    Peptides; 2006 Sep; 27(9):2276-83. PubMed ID: 16762459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the factors influencing cardiac growth. III. Digitoxin treatment and thyroxine-induced cardiac hypertrophy in the rat.
    Nosztray K; Szabó J; Takács IE; Szegi J
    Acta Biol Hung; 1986; 37(3-4):209-18. PubMed ID: 2450432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased collagen mRNA and regression of cardiac fibrosis in the ventricular myocardium of the tight skin mouse following thyroid hormone treatment.
    Yao J; Eghbali M
    Cardiovasc Res; 1992 Jun; 26(6):603-7. PubMed ID: 1451140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and degradation of myocardial protein during the development and regression of thyroxine-induced cardiac hypertrophy in rats.
    Sanford CF; Griffin EE; Wildenthal K
    Circ Res; 1978 Nov; 43(5):688-94. PubMed ID: 152166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
    Kuzman JA; O'Connell TD; Gerdes AM
    Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo collagen turnover during development of thyroxine-induced left ventricular hypertrophy.
    Karim MA; Ferguson AG; Wakim BT; Samarel AM
    Am J Physiol; 1991 Feb; 260(2 Pt 1):C316-26. PubMed ID: 1825450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Promotion of organ circulation by raubasine].
    Dietmann K
    Arzneimittelforschung; 1967 Aug; 17(8):969-75. PubMed ID: 5632071
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroxine-induced cardiomegaly: assessment of nucleic acid, protein content and myosin ATPase of rat heart.
    Szabó J; Nosztray K; Takács I; Szegi J
    Acta Physiol Acad Sci Hung; 1979; 54(1):69-79. PubMed ID: 94743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.